Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henry Blooms Health Products is a pioneering Australian nutraceutical company established in 1938 by Henry Bloom. The company is widely recognized for introducing probiotic culture to the Australian market and remains a leader in bio-fermentation technology. Their extensive product portfolio includes vitamins, minerals, herbal supplements, and specialized probiotic-based oral and personal care products. Operating as a commercial-stage entity, Henry Blooms focuses on high-quality, TGA-regulated formulations designed to support digestive health, immunity, and general wellbeing. The brand is currently a subsidiary of Phytologic Holdings and maintains a significant presence in both domestic and international health retail channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henry Blooms Health Products.